Skip to Content

Focetria

Active Substance: Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/California/7/2009 (H1N1)-derived strain used NYMC X-181 7.5 microgragms per 0.5 ml dose
Common Name: influenza vaccine (H1N1) (surface antigen, inactivated, adjuvanted)
ATC Code: J07BB02
Marketing Authorisation Holder: Novartis Vaccines and Diagnostics S.r.l.
Active Substance: Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/California/7/2009 (H1N1)-derived strain used NYMC X-181 7.5 microgragms per 0.5 ml dose
Status: Withdrawn
Authorisation Date: 2007-05-02
Therapeutic Area: Influenza, Human Immunization Disease Outbreaks
Pharmacotherapeutic Group: Influenza vaccines

Therapeutic Indication

Prophylaxis of influenza caused by A (H1N1v) 2009 virus.

Focetria should be used in accordance with official guidance.

The marketing authorisation for Focetria has been expired following the marketing-authorisation holder's decision not to apply for a renewal.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide